Clearing away the smoke: clinical evidence for medical marijuana with a prescribing guide
A review of clinical trials found cannabinoids useful for neuropathic pain and MS spasticity, and proposed an algorithm to help physicians decide when to recommend cannabis.
Quick Facts
What This Study Found
This review summarized the growing clinical trial evidence for medical cannabis, focusing on recent trials of smoked and vaporized marijuana as well as botanical extracts. The strongest evidence supported cannabinoids for neuropathic pain management and MS spasticity.
The authors noted that the understanding of THC and cannabinoid mechanisms had advanced significantly, providing a scientific basis for therapeutic use. They presented a clinical algorithm for physicians to determine whether cannabis might be appropriate for individual patients, weighing benefits against risks.
The review positioned medical cannabis as a legitimate therapeutic option in jurisdictions where it was permitted, while acknowledging that, like all medications, it required careful benefit-risk assessment.
Key Numbers
Strongest evidence: neuropathic pain and MS spasticity. Clinical algorithm provided for physician decision-making.
How They Did This
Narrative review of recent clinical trials with smoked/vaporized marijuana and cannabis extracts. Developed a clinical decision algorithm for physician guidance.
Why This Research Matters
By providing a practical prescribing algorithm, this review moved the conversation from "should cannabis be medical?" to "how should physicians use it?" This was a significant shift toward treating cannabis as a medicine requiring clinical judgment.
The Bigger Picture
The gap between legal availability and clinical guidance left physicians unprepared. This review, published in a neurology journal, helped fill that gap by synthesizing evidence and providing actionable guidance.
What This Study Doesn't Tell Us
Narrative review without systematic methodology. The clinical algorithm, while practical, was not validated in clinical practice. Evidence was still emerging and limited for most indications beyond pain and spasticity.
Questions This Raises
- ?Does the prescribing algorithm improve clinical outcomes compared to unguided prescribing?
- ?Should cannabis be treated like any other prescription medication in terms of monitoring?
- ?What evidence thresholds should trigger updates to the algorithm?
Trust & Context
- Key Stat:
- First practical prescribing algorithm for medical cannabis
- Evidence Grade:
- Narrative review with clinical algorithm. Synthesizes trial evidence pragmatically but is not a systematic review.
- Study Age:
- Published in 2012. Medical cannabis clinical guidance has expanded considerably since, with more conditions and formulations studied.
- Original Title:
- Medical marijuana: clearing away the smoke.
- Published In:
- The open neurology journal, 6, 18-25 (2012)
- Authors:
- Grant, Igor(10), Atkinson, J Hampton, Gouaux, Ben(2), Wilsey, Barth
- Database ID:
- RTHC-00564
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What conditions have the best evidence for medical cannabis?
At the time of this review, the strongest clinical trial evidence supported cannabis for neuropathic pain (nerve pain) and multiple sclerosis spasticity. Evidence for other conditions was emerging but less established.
How do doctors decide whether to recommend cannabis?
This review proposed a step-by-step algorithm considering the condition, available evidence, previous treatments tried, patient risk factors, and local legal status. The goal was to bring the same clinical reasoning used for other medications to cannabis prescribing.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-00564APA
Grant, Igor; Atkinson, J Hampton; Gouaux, Ben; Wilsey, Barth. (2012). Medical marijuana: clearing away the smoke.. The open neurology journal, 6, 18-25. https://doi.org/10.2174/1874205X01206010018
MLA
Grant, Igor, et al. "Medical marijuana: clearing away the smoke.." The open neurology journal, 2012. https://doi.org/10.2174/1874205X01206010018
RethinkTHC
RethinkTHC Research Database. "Medical marijuana: clearing away the smoke." RTHC-00564. Retrieved from https://rethinkthc.com/research/grant-2012-medical-marijuana-clearing-away
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.